(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol

This compound is an experimental small molecule with the molecular formula C21H23Cl2N5O2 and a molecular weight of approximately 448.35 g/mol[1][6]. It is not approved for use in any country and has no known clinical indications or patents. The primary identified target is cyclin-dependent kinase 2 (CDK2), suggesting it may act as a CDK inhibitor. Such inhibitors are typically investigated for their potential to disrupt cell cycle progression in cancer cells by inhibiting CDKs involved in cell division[1]. No further pharmacological or clinical data are available.

Other names

(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol4-N-(2,5-dichlorophenyl)-2-N-{4-[(2S)-3-(dimethylamino)-2-hydroxypropoxy]phenyl}pyrimidine-2,4-diamine[6]